A detailed history of Ikarian Capital, LLC transactions in Trillium Therapeutics Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 198,400 shares of TRIL stock, worth $0. This represents 0.25% of its overall portfolio holdings.

Number of Shares
198,400
Holding current value
$0
% of portfolio
0.25%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.